Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …
Oppenheimer analysts are weighing in on the Cambridge-based fertility company OvaScience Inc (NASDAQ:OVAS) and biopharmaceutical company Rockwell Medical Inc (NASDAQ:RMTI), with positive ratings. OvaScience Inc In …
Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services …
Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services …
Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …
In a research report released on Friday, Oppenheimer analyst Ling Wang reiterated an Outperform rating on shares of Rockwell Medical Inc (NASDAQ:RMTI) with a …
Recently, various executives have taken part in insider trading activity for the stocks of Skyworks Solutions Inc (NASDAQ:SWKS), Palo Alto Networks Inc (NYSE:PANW), Celldex Therapeutics, …
Brean Capital’s healthcare analyst Jonathan Aschoff weighed in with a negative view on Rockwell Medical Inc (NASDAQ:RMTI), reiterating a Sell rating on the stock, with a $4.00 price …
Rockwell Medical Inc (NASDAQ:RMTI) shares have popped 13.24% to $15.
